跳至主要内容
临床试验/DRKS00007910
DRKS00007910招募中2 期

Augmentation of Interpersonal Psychotherapy (IPT) with D-cycloserine - NeuroIPT-1

niversitätsklinikum Freiburg; Sponsordelegation an Prof. Dr. Claus Normann0 个研究点目标入组 28 人开始时间: 2016年6月9日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
20 Years 至 60 Years(—)
性别
All

入选标准

  • Major depressive disorder (ICD-10: F32.2 and F33.2)
  • - Inpatients at the Department of Psychiatry and Psychotherapy, Freiburg
  • - Score of =15 and = 45 on the 21-item Hamilton Rating Scale for Depression (HAMD)
  • - 20-60 years of age
  • - Ability to provide informed consent
  • - Absence of any exclusion criteria

排除标准

  • Hypersensitivity to D-cycloserine
  • - Neurological disorders including epilepsy, history of brain injury, encephalitis, or any organic brain syndrome
  • - Metallic implants
  • - Present pregnancy
  • - DSM-V axis I disorder (lifetime) apart from major depression, such as schizophrenia, schizoaffective disorder, any non-bipolar psychotic disorder, bipolar disorders, primary anxiety or obsessive compulsive disorder, mental retardation, signs of impaired cognitive functioning
  • - Acute suicidality
  • - Psychotic features of MDD
  • - Lifetime history for drug/alcohol dependence, or drug/alcohol abuse within the past year - Antidepressive pharmacotherapy other than monotherapy with SSRI, bupropion or venlafaxine
  • - Medical conditions including severe cardiac, liver, kidney, endocrine (e.g., diabetes), hematologic disorders (e.g., porphyria or any bleeding abnormalities), other impairing or unstable medical condition or impending surgery
  • - Inability to read or understand the study forms and agree to informed consent.
  • - Left-handedness

研究者

发起方
niversitätsklinikum Freiburg; Sponsordelegation an Prof. Dr. Claus Normann

相似试验

Augmentation of Interpersonal Psychotherapy (IPT)... | 临床试验